| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,575,000 | 3,103,000 | 3,619,000 | 3,834,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 3,575,000 | 3,103,000 | 3,619,000 | 3,834,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,816,000 | 2,867,000 | 3,508,000 | 2,999,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 759,000 | 236,000 | 111,000 | 835,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,000) | 22,000 | 17,000 |
-
| | Earnings Before Interest And Taxes | 746,000 | 161,000 | 115,000 | 945,000 | | Interest Expense | 54,000 | 54,000 | 68,000 | 62,000 | | Income Before Tax | 692,000 | 107,000 | 47,000 | 883,000 | | Income Tax Expense | 125,000 | 87,000 | (7,000) | 137,000 | | Minority Interest |
-
| 7,000 | (3,000) | (4,000) | | | | Net Income From Continuing Ops | 567,000 | 20,000 | 54,000 | 746,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 567,000 | 20,000 | 54,000 | 746,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $567,000 | $20,000 | $54,000 | $746,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
